These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9229787)

  • 41. Recycled heart valves from transplant patients.
    Feindel CM; David TE; Bos J; Daly PA; Cardella CJ
    J Heart Lung Transplant; 1991; 10(4):614-6; discussion 616-7. PubMed ID: 1911809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allograft tissue for use in valve replacement.
    Da Costa ML; Ghofaili FA; Oakley RM
    Cell Tissue Bank; 2006; 7(4):337-48. PubMed ID: 16821110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European homograft bank: twenty years of cardiovascular tissue banking and collaboration with transplant coordination in Europe.
    Jashari R; Goffin Y; Vanderkelen A; Van Hoeck B; du Verger A; Fan Y; Holovska V; Brahy O
    Transplant Proc; 2010; 42(1):183-9. PubMed ID: 20172310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Allograft (homograft) valve surgery: current status in Japan].
    Kitamura S; Niwaya K; Kawachi K; Morita R; Kawata T; Kobayashi S; Fukutomi M; Hasegawa J; Yoshida Y; Sakaguchi H
    Rinsho Kyobu Geka; 1994 Aug; 14(4):273-9. PubMed ID: 9423100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Valve replacement with cryopreserved allograft].
    Kobayashi T; Makuuchi H; Naruse Y; Goto M; Tanaka K; Arimura Y; Katsu M
    Kyobu Geka; 2000 Apr; 53(4):286-9. PubMed ID: 10770054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term storage in liquid nitrogen does not affect cell viability in cardiac valve allografts.
    Mirabet V; Carda C; Solves P; Novella-Maestre E; Carbonell-Uberos F; Caffarena JM; Hornero F; Montero JA; Roig RJ
    Cryobiology; 2008 Oct; 57(2):113-21. PubMed ID: 18703039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies.
    O'Brien MF; Stafford EG; Gardner MA; Pohlner PG; McGiffin DC
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):812-23. PubMed ID: 3682851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of immunogenicity and viability of homologous human cardiac valves in vitro.
    Ketheesan N; Kearney JN; Ingham E
    J Heart Valve Dis; 1996 Mar; 5(2):144-7. PubMed ID: 8665005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gamma ray sterilisation of homograft valves.
    Gibbons JR; Alladine F
    Bull Soc Int Chir; 1969; 28(3):353-8. PubMed ID: 5400555
    [No Abstract]   [Full Text] [Related]  

  • 50. The time has come to extend the expiration limit of cryopreserved allograft heart valves.
    Burkert J; Kochová P; Tonar Z; Cimrman R; Blassová T; Jashari R; Fiala R; Špatenka J
    Cell Tissue Bank; 2021 Jun; 22(2):161-184. PubMed ID: 32583302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathological considerations in cryopreserved allograft heart valves.
    Schoen FJ; Mitchell RN; Jonas RA
    J Heart Valve Dis; 1995 Jul; 4 Suppl 1():S72-5; discussion S75-6. PubMed ID: 8581216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of aortic valve replacement with pulmonary and aortic homografts.
    Naegele H; Bohlmann M; Döring V; Kalmar P; Rödiger W
    J Heart Valve Dis; 2000 Mar; 9(2):215-20; discussion 220-1. PubMed ID: 10772039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homograft valves.
    Barratt-Boyes B; Roche A; Agnew TM; Cole D; Kerr A; Monro JL; Lowe JB; Brandt PW
    Med J Aust; 1972 Aug; 2(1):Suppl:38-44. PubMed ID: 4637362
    [No Abstract]   [Full Text] [Related]  

  • 54. Homograft replacement of the atrioventricular valves.
    Robicsek F
    J Heart Valve Dis; 1996 Nov; 5(6):607-22. PubMed ID: 8953438
    [No Abstract]   [Full Text] [Related]  

  • 55. Allogenic heart valve bank in the Department of Cardiovascular Surgery and Transplantology of Jagiellonian University in Cracow - 23 years experience in the treatment of aortic valve or aortic root diseases.
    Stoliński J; Marek G; Marcinkowska Z; Jaskier M; Barecka D; Bartuś K; Kapelak B; Sadowski J; Dziatkowiak A
    Cell Tissue Bank; 2006; 7(3):175-82. PubMed ID: 16933039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A fresh, viable human heart valve bank: sterilization, sterility testing, and cryogenic preservation.
    Angell JD; Christopher BS; Hawtrey O; Angell WM
    Transplant Proc; 1976 Jun; 8(2 Suppl 1):139-47. PubMed ID: 821184
    [No Abstract]   [Full Text] [Related]  

  • 57. Risk factors for rejection for morphological reasons of heart valves for transplantation.
    van Wijk MJ; van den Bogaerdt A; Bokhorst AG
    Cell Tissue Bank; 2013 Mar; 14(1):125-32. PubMed ID: 21744230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tissue valve as a superior cardiac valve replacement.
    Angell WW; Angell JD; Sywak A; Kosek JC
    Surgery; 1977 Dec; 82(6):875-87. PubMed ID: 412262
    [No Abstract]   [Full Text] [Related]  

  • 59. Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation.
    Thatte HS; Rousou L; Hussaini BE; Lu XG; Treanor PR; Khuri SF
    Circulation; 2009 Oct; 120(17):1704-13. PubMed ID: 19822811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hydrodynamics of disk artificial heart valves with different design characteristics].
    Dobrova NB; Zaretskiĭ IuV
    Med Tekh; 1989; (6):3-9. PubMed ID: 2622304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.